Edit Content
Click on the Edit Content button to edit/add the content.

Customers

Locus Featured Customers

Utilizing a wide range of mobile devices, an innovative and flexible population health advocate team at UVA, and deep integration into the Epic EMR (including ordering, discrete data utilization, and billing for RPM reimbursement), the UVA Health program is truly state-of-the art, supporting a wide range of adult and pediatric populations with both post-acute and chronic conditions.

Vergales BD, Murray PD, Miller SE, Vergales JE. Safety and efficacy of a home nasogastric monitoring program for premature infants. J Neonatal Perinatal Med. 2022;15(1):165-170. doi:10.3233/NPM-210790

Vergales J, Peregoy L, Zalewski J, Plummer ST. Use of a Digital Monitoring Platform to Improve Outcomes in Infants With a Single Ventricle. World J Pediatr Congenit Heart Surg. 2020;11(6):753-759. doi:10.1177/2150135120945596

During the COVID pandemic, Inova Schar Cancer Institute piloted an innovative RPM program to keep vulnerable patients undergoing chemotherapy from adverse events, a program for which strong outcomes were reported in the Journal of Clinical Oncology Practice.  ISCI continues to work with Locus as a National Cancer Institute demonstration pilot site for Locus’ NIH/SBIR award and is establishing new standards of care for outpatient chemotherapy adverse event management using the Locus platform and a range of innovative mobile devices (e.g. AppleWatch).

Steimer M, Leabo J, Wang H, et al. Remote Home Monitoring of Patients With Cancer During the COVID Pandemic: A Pilot Study. JCO Oncol Pract. 2021;17(9):e1286-e1292. doi:10.1200/OP.20.00995

In particular, the BCH team is working with Locus to deliver the most innovative integration between RPM capabilities and the Epic EMR in Pediatrics, across an enterprise-wide range of acute and chronic pediatric populations.

Since 2020, Locus has been the recipient of Phase I and Phase II awards from the Small Business Innovation Research (SBIR) program sponsored by the National Institute of Health (NIH) through the National Cancer Institute (NCI). Locus was selected by NCI to commercialize its platform for use with Oncology patients by developing a Cancer Navigation Platform, pursuing a rigorous Phase I research effort and ongoing Phase II commercialization studies and technical research and development.  Both UVA Cancer Center and Inova’s Schar Cancer Institute are deployment partners with Locus in this effort, and strategic advisors to the project include leaders from Cancer Centers at Duke, Ohio State, University of Kansas, and Yale. The current Phase II award is funded in its entirety under Federal Award (NIH/NCI) #75N91022C00038.

Over time, Locus has partnered with the OSHU Digital Health team to identify a wider range of key populations to be supported on the Locus platform, including both Adult Orthopedic and Maternal Health populations, each of which are leveraging the Locus platform’s configurability.

Meet more of our customers

Why Locus

What our customers are saying

“The first question any parent asks when their child is admitted to the NICU is ‘When can we go home?’ Locus is allowing us to help some families return to their normal daily lives faster because we know babies thrive most in their home environment. It’s a real game changer.”

Dr. Cristina Miller,

Neonatologist at Children’s Minnesota

“After researching other remote monitoring platforms, there was no question that integrating Locus was hands down the best option for us. This turn-key program is unlike any other.”

Julie M. Stumpf, RN, MSN,

Manager Cardiac Neurodevelopment Clinic, St. Louis Children's Hospital

“The Locus Platform serves as a common thread that runs through all our Population Health programs…. The vital integration between Locus and our EMR platform, Epic, enables departments to automate orders and allows providers and care teams to see data in real-time…. Locus Health is an excellent partner.”

Novella W. Thompson,

Hospital Administrator (Population Health), UVA Health System

Campbell DJT, Tonelli M, Hemmelgarn BR, et al. Self-Management Support Using Advertising Principles for Older Adults With Low Income at High Cardiovascular Risk: A Randomized Controlled Trial. Circulation. 2023;147(20):1492-1504. doi:10.1161/CIRCULATIONAHA.123.064189

Hartman D, Ebenroth E, Farrell A. Utilizing technology to expand home monitoring to high-risk infants with CHD. Cardiol Young. 2023;33(7):1124-1128. doi:10.1017/S1047951122002232

Huff KA, Cruse W, Vanderpool C. Lipid strategies to prevent intestinal failure-associated liver disease in neonates: A pilot trial. JPEN J Parenter Enteral Nutr. 2023;47(4):482-493. doi:10.1002/jpen.2483

Carrington, Scott et al. Remote Monitoring of Pediatric VAD Patients: Early Recognition for Improved Management. The Journal of Heart and Lung Transplantation. 2022. DOI:10.1016/j.healun.2022.01.253

Vergales BD, Murray PD, Miller SE, Vergales JE. Safety and efficacy of a home nasogastric monitoring program for premature infants. J Neonatal Perinatal Med. 2022;15(1):165-170. doi:10.3233/NPM-210790

Vergales J, Peregoy L, Zalewski J, Plummer ST. Use of a Digital Monitoring Platform to Improve Outcomes in Infants With a Single Ventricle. World J Pediatr Congenit Heart Surg. 2020;11(6):753-759. doi:10.1177/2150135120945596

Mejia E, Zalewski J, Plummer ST. Adapting Interstage Home Monitoring with the use of Telemedicine During the COVID-19 Pandemic. Pediatr Cardiol. 2022;43(5):1136-1140. doi:10.1007/s00246-022-02835-x

Huff KA, Cruse W, Vanderpool C. Lipid strategies to prevent intestinal failure-associated liver disease in neonates: A pilot trial. JPEN J Parenter Enteral Nutr. 2023;47(4):482-493. doi:10.1002/jpen.2483

Steimer M, Leabo J, Wang H, et al. Remote Home Monitoring of Patients With Cancer During the COVID Pandemic: A Pilot Study. JCO Oncol Pract. 2021;17(9):e1286-e1292. doi:10.1200/OP.20.00995

Foster CC, Steltzer M, Snyder A, et al. Integrated Multimodality Telemedicine to Enhance In-Home Care of Infants During the Interstage Period. Pediatr Cardiol. 2021;42(2):349-360. doi:10.1007/s00246-020-02489-7

Vergales J, Peregoy L, Zalewski J, Plummer ST. Use of a Digital Monitoring Platform to Improve Outcomes in Infants With a Single Ventricle. World J Pediatr Congenit Heart Surg. 2020;11(6):753-759. doi:10.1177/2150135120945596